CollPlant Biotechnologies Ltd. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K was filed by CollPlant Biotechnologies Ltd., a foreign private issuer, for the month of September 2021. The filing date is September 9, 2021. The registrant is headquartered in Rehovot, Israel.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report serves solely to disseminate a corporate press release and does not contain financial statements or performance data.
Material Changes
No material financial changes versus the prior comparable period are reported in this document. The filing discloses a corporate governance update: CEO Yehiel Tal was elected to the Board of Directors of the International Society for Biofabrication (ISBF).
Guidance, Outlook, and Risks
The filing contains no management commentary regarding financial guidance, future outlook, risks, contingencies, or unusual items. The content is limited to the announcement of the CEO's election to the ISBF Board.
Key Facts for Investor Verification
- The filing is a non-financial report (Form 6-K) referencing a press release (Exhibit 99.1).
- CEO Yehiel Tal has been elected to the Board of Directors of the International Society for Biofabrication (ISBF).
- No financial performance data is included in this specific filing.
- The report was signed by Eran Rotem, Deputy CEO and Chief Financial Officer.